Pharma Deko Plc (NGX:PHARMDEKO)
Nigeria flag Nigeria · Delayed Price · Currency is NGN
1.830
0.00 (0.00%)
At close: Aug 14, 2026

Pharma Deko Statistics

Total Valuation

Pharma Deko has a market cap or net worth of NGN 396.78 million. The enterprise value is 418.77 million.

Market Cap396.78M
Enterprise Value 418.77M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Pharma Deko has 216.82 million shares outstanding.

Current Share Class 216.82M
Shares Outstanding 216.82M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.84
PB Ratio 0.39
P/TBV Ratio 0.39
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.89
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.21, with a Debt / Equity ratio of 0.03.

Current Ratio 0.21
Quick Ratio 0.06
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF -0.95
Interest Coverage -31.97

Financial Efficiency

Return on equity (ROE) is -25.54% and return on invested capital (ROIC) is -25.68%.

Return on Equity (ROE) -25.54%
Return on Assets (ROA) -7.80%
Return on Invested Capital (ROIC) -25.68%
Return on Capital Employed (ROCE) -26.59%
Weighted Average Cost of Capital (WACC) 4.94%
Revenue Per Employee 9.39M
Profits Per Employee -5.92M
Employee Count 50
Asset Turnover 0.21
Inventory Turnover 2.23

Taxes

In the past 12 months, Pharma Deko has paid 2.49 million in taxes.

Income Tax 2.49M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) -0.13
52-Week Price Change n/a
50-Day Moving Average 1.83
200-Day Moving Average 1.83
Relative Strength Index (RSI) 41.10
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Pharma Deko had revenue of NGN 469.58 million and -296.19 million in losses. Loss per share was -1.37.

Revenue469.58M
Gross Profit 97.62M
Operating Income -285.38M
Pretax Income -293.70M
Net Income -296.19M
EBITDA -216.37M
EBIT -285.38M
Loss Per Share -1.37

Balance Sheet

The company has 9.79 million in cash and 31.78 million in debt, with a net cash position of -21.99 million or -0.10 per share.

Cash & Cash Equivalents 9.79M
Total Debt 31.78M
Net Cash -21.99M
Net Cash Per Share -0.10
Equity (Book Value) 1.01B
Book Value Per Share 4.66
Working Capital -918.91M

Cash Flow

In the last 12 months, operating cash flow was -28.69 million and capital expenditures -4.66 million, giving a free cash flow of -33.36 million.

Operating Cash Flow -28.69M
Capital Expenditures -4.66M
Depreciation & Amortization 69.01M
Net Borrowing 3.78M
Free Cash Flow -33.36M
FCF Per Share -0.15

Margins

Gross margin is 20.79%, with operating and profit margins of -60.77% and -63.07%.

Gross Margin 20.79%
Operating Margin -60.77%
Pretax Margin -62.54%
Profit Margin -63.07%
EBITDA Margin -46.08%
EBIT Margin -60.77%
FCF Margin n/a

Dividends & Yields

Pharma Deko does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -74.65%
FCF Yield -8.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Pharma Deko has an Altman Z-Score of -1.28 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.28
Piotroski F-Score 2